Luke H. Stockwin

Statistics

Publications

Citations

1.1K

H-Index

Active since

1999

Affiliations

Science Applications International Corporation (United States)(Current)

Frederick National Laboratory for Cancer Research

National Cancer Institute

Center for Cancer Research

University of Leeds

Luke H. Stockwin is an author at Science Applications International Corporation (United States) specializing in oncology, life sciences, and molecular oncology.

Publications per year

1999–2018

Publications

Sodium dichloroacetate selectively targets cells with defects in the mitochondrial ETC

Luke H. Stockwin, Sherry X. Yu, Suzanne Borgel et al. · International Journal of Cancer · 2010 · 156 citations

Medicine, Oncology, Pharmacology +17

A copper chelate of thiosemicarbazone NSC 689534 induces oxidative/ER stress and inhibits tumor growth in vitro and in vivo

Chad N. Hancock, Luke H. Stockwin, Bingnan Han et al. · Free Radical Biology and Medicine · 2010 · 115 citations

Medicine, Oncology, Pharmacology +9

Artemisinin dimer anticancer activity correlates with heme‐catalyzed reactive oxygen species generation and endoplasmic reticulum stress induction

Luke H. Stockwin, Bingnan Han, Sherry X. Yu et al. · International Journal of Cancer · 2009 · 103 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Gene expression profiling of alveolar soft-part sarcoma (ASPS)

Luke H. Stockwin, David T. Vistica, Susan Kenney et al. · BMC Cancer · 2009 · 96 citations · Full text

Medicine, Cancer Biology, Oncology +14

The “survivin suppressants” NSC 80467 and YM155 induce a DNA damage response

Trevor Glaros, Luke H. Stockwin, Michael E. Mullendore et al. · Cancer Chemotherapy and Pharmacology · 2012 · 95 citations

Life Sciences, Molecular Biology, Apoptosis +14

1–5 of 18